Eastman Chemical (NYSE: EMN) reported Q2 EPS of $2.83, $0.15 better than the analyst estimate of $2.68. Revenue for the quarter came in at $2.78 billion versus the consensus estimate of $2.77 billion.

GUIDANCE:

Eastman Chemical sees FY2022 EPS of $9.50-$10.00, versus the consensus of $9.80.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.